Trial Information
Summary: Entrance into the International Fanconi Anemia Registry (IFAR)
To obtain clinical and genetic information on patients with this
heterogeneous disorder, in order to learn how to optimize growth
and development of affected children, and to increase our
understanding of this rare syndrome.
Patients affected with Fanconi anemia will be admitted to The
Rockefeller University Hospital for 3-5 days. They will receive a
complete physical examination and drawing of blood for various
laboratory studies. Consultations with subspecialists in genetics,
hematology, endocrinology, gastroenterology, neurology,
dermatology, etc. will be obtained as warranted. Genetic counseling
and dietary instruction will be provided. Since growth failure
associated with endocrine abnormalities is one of the most common
findings in FA, and one of the least studied, we will evaluate
patients for growth hormone, glucose metabolism, thyroid function,
adrenal function and pubertal function.
|
Contact:
Arleen D. Auerbach, Ph.D.
The Rockefeller University Hospital
1230 York Avenue
New York, NY 10021-6399
Telephone: 212-327-7533
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:43:16 AM